Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Mayne Pharma Group ( (AU:MYX) ) is now available.
Mitsubishi UFJ Financial Group, through its subsidiary First Sentier Investors Holdings Pty Limited, has acquired a substantial holding in Mayne Pharma Group Ltd. This acquisition grants them significant voting power and influence over the company’s operations, reflecting a strategic investment move that could impact Mayne Pharma’s market positioning and stakeholder interests.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 936,280
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$407.9M
Learn more about MYX stock on TipRanks’ Stock Analysis page.